newsfilter
← Latest News
PR Newswire·

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today...